MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

<< Previous

Bullboard Posts

Next >>

Post by august202013on Feb 26, 2021 11:22am

191 Views

Post# 32671080

MIR IDENTIFIED AS 1ST MAJOR TOOL FOR 2ND CHAPTER

Minor pull back should NOT deter anyone NOT sure why BUT will not deter any long term individual shareholders as quite sure temporary and as quite sure most have used up all COINs to take up any thrown at NOW. In chapter 2 will CERTAINLY make some provision/contingency for this kind of prolonged delay. Continue to wait things should get better.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages